Inhaled Insulin (Exubera)

DRUG3 trials

Sponsors

Pfizer

Conditions

Diabetes Mellitus Type 2Diabetes Mellitus, Type 1Diabetes Mellitus, Type 2

Phase 3

A Clinical Trial Assessing The Impact Of Inhaled Insulin On Glucose Control In Patients With Type 2 Diabetes Mellitus

TerminatedNCT00282971

PfizerDiabetes Mellitus Type 2

Start: 2006-03-06End: 2008-02-19Updated: 2019-04-02

Safety And Efficacy Of Exubera Compared With Subcutaneous Human Insulin Therapy In Children And Adolescents

TerminatedNCT00479258

PfizerDiabetes Mellitus, Type 1

Start: 2007-10-31End: 2007-10-31Updated: 2018-10-01

Phase 4

This Study Is To Determine If Inhaled Insulin Is Effective In Treating Type 2 Diabetes Mellitus

CompletedNCT00418522

PfizerDiabetes Mellitus, Type 2

Start: 2007-03-01End: 2008-08-01Updated: 2026-08-11

Related Papers

How many unpublished studies? ClinicalTrials.gov (n = 2614 studies): diabetes | Closed Studies | Interventional Studies | Phase 3, 4 | Search Date: Oct 27, 2014

Figshare2014-01-01